Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR)

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

April 1, 2025

Conditions

Autoimmune Pancreatitis Type 1Autoimmune Pancreatitis Type 2

All Listed Sponsors

collaborator

University Medical Centre Maribor

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

University Hospital Munich

OTHER

collaborator

Tartu University Hospital

OTHER

collaborator

University Hospital in Halle

OTHER

lead

University Medical Center Goettingen

OTHER

NCT06328101 - Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR) | Biotech Hunter | Biotech Hunter